How will you manage your Temporary Authorization for Use (ATU) in France?
Our webinar will provide you with the following key learning objectives:
- Feasibility assessment for ATU: regulatory and market access strategy – PharmaLex
- Overcoming operational hurdles of ATU: how SmartClinica can help you? – Adalys
- Questions and Answers – Adalys and PharmaLex
If you want to know more, please register to view the live webinar or to receive the on-demand recording after the event.
About the Speakers:
Senior Director Drug Development and Vigilance
Patrick has a wealth of experience focusing on the development of drugs and biologics, as well as Companion Diagnostic tests. His expertise lies in the design and implementation of regulatory strategies at all stages of clinical development for complex and innovative medicinal products, interactions with EU Regulatory Agencies , co-development of IVDs and drugs.
CEO and Founder of Adalys
Anne Grassin combines over 10 years of experience project and team management with emphasis on delivering solutions and services for the pharmaceutical industry. She completed her masters program in International Business at the Business School of Montpellier and Arnhem Business School. She founded Adalys in 2015 to develop a new software to manage clinical trials adapted to the evolving and challenging medical environment.